⚠ You're viewing a report from January 2023. Subscribe to get the latest →

FDA Enforcement — January 2023 Report

Automated analysis of 46 items from public government data sources. Updated daily.

Summary

46
Total items
37
High impact
9
Medium impact
0
Low impact

High-impact items this period

Old Tiles Wallpaper, LLC DBA Old Tiles Decor
Unapproved misbranded drug products marketed illegally
Why: Marketing unapproved pharmaceuticals with false therapeutic claims  ·  Jan 30  ·  Impact: HIGH
Noble Elements, LLC
Unapproved misbranded drug products marketed illegally
Why: Marketing unapproved pharmaceuticals with false therapeutic claims  ·  Jan 30  ·  Impact: HIGH
Lyons Magnus, LLC
Low acid canned food adulteration regulation violations
Why: Inadequate controls in low acid canned food processing  ·  Jan 30  ·  Impact: HIGH
Fei Fah Medical Manufacturing Pte. Ltd.
Pharmaceutical product adulterated under CGMP
Why: Failure to comply with current Good Manufacturing Practice requirements  ·  Jan 30  ·  Impact: HIGH
Dr. Green Mom, LLC
Unapproved new drug and misbranded finished pharmaceutical product
Why: Marketing unapproved pharmaceutical products without FDA authorization  ·  Jan 30  ·  Impact: HIGH
Clean Cosmetics LLC
Adulterated finished pharmaceuticals CGMP violations
Why: Current good manufacturing practice violations in pharmaceutical production  ·  Jan 30  ·  Impact: HIGH
Monkeypox-treatment.com
Unapproved misbranded drug products marketed illegally
Why: Marketing unapproved pharmaceuticals with false therapeutic claims  ·  Jan 30  ·  Impact: HIGH
Organic Heirloom Plants
Unapproved misbranded drug products marketed illegally
Why: Marketing unapproved pharmaceuticals with false therapeutic claims  ·  Jan 30  ·  Impact: HIGH
Shenzhen GreenSound High-Tech Co., LTD d/b/a Vaporlax
Tobacco product misbranding and adulteration violations
Why: Unapproved tobacco products marketed without required labeling or approval  ·  Jan 27  ·  Impact: HIGH
Kobayashi Healthcare International, Inc.
Adulterated finished pharmaceuticals, CGMP violations
Why: Manufacturing facility failed current good manufacturing practice standards  ·  Jan 27  ·  Impact: HIGH

Selected medium-impact items

Desert Defense, LLC
Unapproved new animal drug products distributed
Why: Manufacturing and distribution of unapproved veterinary pharmaceutical products  ·  Jan 26  ·  Impact: MEDIUM
Adept Life Science, LLC
Misbranded dietary supplement CGMP violations
Why: Dietary supplement manufacturing and labeling practice violations  ·  Jan 24  ·  Impact: MEDIUM
Sohgave LLC
Foreign supplier verification program non-compliance
Why: Inadequate verification of foreign food suppliers and controls  ·  Jan 19  ·  Impact: MEDIUM
Southbound Vapes
Tobacco product adulteration and misbranding violations
Why: Non-compliance with Smoking Prevention and Tobacco Control Act  ·  Jan 19  ·  Impact: MEDIUM
Modfathers Vapor
Tobacco product adulteration and misbranding violations
Why: Non-compliance with Smoking Prevention and Tobacco Control Act  ·  Jan 19  ·  Impact: MEDIUM

Get this delivered every week

Free tier: 3 items per vertical. Full access with paid subscription.

Subscribe — $29/mo →

Data sourced from public government APIs. AI analysis via Claude Haiku. Full methodology →